The purchase is the first part of GMED’s strategy to acquire implant and metallurgical technology with a proven safety record and long history of clinical use to combine with their robotic technology.
We asked representatives from three testing companies about the questions they get most often, and the latest updates to regulations and standards. Here, we recap their advice.
Hard work combined with strategic innovation allowed NuVasive to successfully design, qualify and bring to market an optimized family of AM implants in 14 months.
As hospitals and outpatient centers strive to become more efficient with their time and money, improving the logistics of surgical instruments has come to the forefront. The CrossRoads EcoSmart Instrument Recovery Services program provides a unique approach.
This article provides a description of ambulatory settings and strategies, and offers insight on ways that device companies can capitalize on the shift from inpatient surgical settings to hospital outpatient departments, ambulatory surgery centers and outpatient sites of care.
Save the Dates: June 9-11 | Chicago
Now Accepting Booth Applications - the exhibit floor is 50% full at this time.
Get your application.
Education is currently in development. Send your suggestions to
Carolyn LaWell.
A huge concern for hospitals, surgeons and patients is the potential for infection after a surgical procedure. Jason Haider, Founder and CEO of Xenco Medical, decided to do something about that.
Medacta is introducing the Mecta®Lock PEEK Suture Anchor and the Mecta®Screw PEEK Interference Screw in these regions, growing the reach of its sports medicine segment.
As the ecosystem strategy creates opportunities to take market share and improve sales mix, companies strive to be ready with a robust portfolio of up-to-date implants.
